VARIABILITY OF PULMONARY-FUNCTION TESTS IN CYSTIC-FIBROSIS

被引:75
|
作者
COOPER, PJ [1 ]
ROBERTSON, CF [1 ]
HUDSON, IL [1 ]
PHELAN, PD [1 ]
机构
[1] ROYAL CHILDRENS HOSP, PROF DEPT THORAC MED, PARKVILLE, VIC 3052, AUSTRALIA
关键词
effect of disease severity; Lung volumes; maximum flows; maximum pressures; reference values for significant changes; spirometry; within‐subject coefficient of variation;
D O I
10.1002/ppul.1950080107
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The aim of this study was to define the within‐subject variability for tests of respiratory function in patients with cystic fibrosis (CF) within the day, from day to day and from week to week. Twenty‐eight patients with CF (aged 9–19 years) and 23 healthy height matched controls (aged 9–18 years) had measurements made of spirometry, lung volumes, maximal flows at three lung volumes and maximal inspiratory and expiratory pressures at the mouth. Testings were done on nine occasions, three times within a day, on consecutive days at one week intervals. Each individual's variability was summarized both as the within‐subject coefficient of variation (WCV) and within‐subject standard deviation (WSD). Means of WSD and median WCV are reported for both the patients with CF and normal subjects. The within‐subject variability of VC, FEV1, TLC, RV, and RV/TLC was more appropriately assessed by the use of WSD rather than WCV. The WSDs in the CF group were significantly more variable (P <0.005) than in the normals for VC and FEV1. WCV best summarized within‐subject variation for FEF25–75, FRC, V̇25, V̇50max and V̇75max for which the CF subjects were significantly more variable (P <0.005). Individuals' variability was very consistent, therefore assessment of significant change could be made more accurately by predetermining the variability of that individual, rather than using group data. We stress the importance to consider increased variability from day to day and week to week in the interpretation of change in lung function in patients with CF, and provide reference values for accurate interpretation of serial pulmonary function test results. Pediatr Pulmonol 1990; 8:16‐22. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:16 / 22
页数:7
相关论文
共 50 条
  • [1] NOCTURNAL HYPOXEMIA IN CYSTIC-FIBROSIS - RELATIONSHIP TO PULMONARY-FUNCTION TESTS
    SMITH, DL
    FREEMAN, W
    CAYTON, RM
    STABLEFORTH, DE
    RESPIRATORY MEDICINE, 1994, 88 (07) : 537 - 539
  • [2] KYPHOSIS AND PULMONARY-FUNCTION IN CYSTIC-FIBROSIS
    LOGVINOFF, MM
    FON, GT
    TAUSSIG, LM
    PITT, MJ
    CLINICAL PEDIATRICS, 1984, 23 (07) : 389 - 392
  • [3] RESTRICTED PULMONARY-FUNCTION IN CYSTIC-FIBROSIS
    RIES, AL
    SOSA, G
    PREWITT, L
    FRIEDMAN, PJ
    HARWOOD, IR
    CHEST, 1988, 94 (03) : 575 - 579
  • [4] PULMONARY-FUNCTION IN INDIVIDUALS HETEROZYGOUS FOR CYSTIC-FIBROSIS
    SPEIZER, FE
    TISHLER, PV
    AMERICAN JOURNAL OF HUMAN GENETICS, 1978, 30 (03) : 330 - 330
  • [5] THROMBOXANE BIOSYNTHESIS AND PULMONARY-FUNCTION IN CYSTIC-FIBROSIS
    DAVI, G
    IAPICHINO, L
    BALSAMO, V
    CATALANO, I
    NOTARBARTOLO, A
    PATRONO, C
    CLINICAL RESEARCH, 1993, 41 (02): : A251 - A251
  • [6] THE EFFECT OF EXERCISE ON PULMONARY-FUNCTION IN CYSTIC-FIBROSIS
    FIELD, PI
    MORTON, JR
    AUSTRALIAN PAEDIATRIC JOURNAL, 1986, 22 (04): : 335 - 336
  • [7] RELATIONSHIP OF NUTRITION AND PULMONARY-FUNCTION IN CYSTIC-FIBROSIS
    HARPER, TB
    JOURNAL OF PEDIATRICS, 1983, 103 (01): : 164 - 164
  • [8] PULMONARY-FUNCTION IN OBLIGATE HETEROZYGOTES FOR CYSTIC-FIBROSIS
    BYARD, PJ
    DAVIS, PB
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (02): : 312 - 316
  • [9] THROMBOXANE BIOSYNTHESIS AND PULMONARY-FUNCTION IN CYSTIC-FIBROSIS
    DAVI, G
    LAPICHINO, L
    BALSAMO, V
    CATALANO, I
    NOTARBARTOLO, A
    PATRONO, C
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 748 - 748
  • [10] THROMBOXANE BIOSYNTHESIS AND PULMONARY-FUNCTION IN CYSTIC-FIBROSIS
    DAVI, G
    IAPICHINO, L
    BALSAMO, V
    GANCI, A
    GIAMMARRESI, C
    PATRIGNANI, P
    PATRONO, C
    PROSTAGLANDINS AND RELATED COMPOUNDS: NINTH INTERNATIONAL CONFERENCE, FLORENCE, ITALY, 1995, 23 : 369 - 371